Vista Current Coverage

All Atossa Genetics, Inc. Articles

Breast Cancer Innovator Atossa Genetics Receives Second Positive Interim Safety Review from Independent Safety Committee in Study of Men With Male Breast Enlargement

Seattle based Atossa Genetics Inc. (ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, has received a second positive interim safety review on its Phase 1 study of topical Endoxifen in men, which is being...

“On The Rebound?” Vista Partners Weekly Market Update 5-12-18

Vista Partners has published “On The Rebound?” Vista Partners Weekly Market Update 5-12-18 and is accessible on our Newsletters Page. Each issue is written by Managing Director, John Heerdink and speaks to the activities of the market, influencers and specific featured stories from Vista’s Coverage Universe...

“Mixed?” Vista Partners Weekly Market Update 5-5-18

Vista Partners has published “Mixed?” Vista Partners Weekly Market Update 5-5-18 and is accessible on our Newsletters Page. Each issue is written by Managing Director, John Heerdink and speaks to the activities of the market, influencers and specific featured stories from Vista’s Coverage Universe that spans...

Vista Partners Publishes April’s FREE Macroeconomic & Investment Monthly Newsletter, “U.S. Economy Remains Strong, Anticipating Steady Growth With Rate Twist”

Vista Partners (“Vista”) has published April’s FREE Macroeconomic & Investment Monthly Newsletter, “U.S. Economy Remains Strong, Anticipating Steady Growth With Rate Twist.” Vista’s monthly newsletter contains investment considerations for Banks, Biotech, Cloud Services, Energy, Fintech, Healthcare, Manufacturing, Materials, Real Estate, SaaS, and Technology. Vista Partners centers...